About us_About us_Chongqing Huapont Shengchem Pharm. Co., Ltd.

Participate CPhI Worldwide 2024

2024/05/09

Participate CPhI Worldwide 2024

Time：October 8-10, 2024
Location：Milan, Italy
Please send email to api@huapont.cn to make an appointment for meeting. We’ll see you there

View More →

Time：October 8-10, 2024
Location：Milan, Italy
Please send email to api@huapont.cn to make an appointment for meeting. We’ll see you there

Participate CPhI China 2024

2024/05/09

Participate CPhI China 2024

Time：June 19-21, 2024
Location：Shanghai, China
Please send email to api@huapont.cn to make an appointment for meeting. We’ll see you there

View More →

Time：June 19-21, 2024
Location：Shanghai, China
Please send email to api@huapont.cn to make an appointment for meeting. We’ll see you there

Participate API China 2023

2024/05/09

Participate API China 2023

Time：May 15-17, 2024
Location：Shanghai, China
Please send email to api@huapont.cn to make an appointment for meeting. We’ll see you there

View More →

Time：May 15-17, 2024
Location：Shanghai, China
Please send email to api@huapont.cn to make an appointment for meeting. We’ll see you there

Huapont Team to Participate CPhI Worldwide 2024 (October 8-10, Booth No.: 2B42)

2024/04/27

Huapont Team to Participate CPhI Worldwide 2024 (October 8-10, Booth No.: 2B42)

Huapont will be actively participating in CPhI Worldwide 2024 (Booth No.: 2B42). This prestigious event, aiming on serving a global community – advancing human health, will take place from October 8 to October 10, 2024, in Milan, Italy.

View More →

Huapont will be actively participating in CPhI Worldwide 2024 (Booth No.: 2B42). This prestigious event, aiming on serving a global community – advancing human health, will take place from October 8 to October 10, 2024, in Milan, Italy.

Huapont Team to Participate CPhI China 2024 (June 19-21, Booth No.: W3E52b).

2024/04/26

Huapont Team to Participate CPhI China 2024 (June 19-21, Booth No.: W3E52b).

Huapont will be actively participating in CPhI China 2024 (Booth No.: W3E52b). This prestigious event, turning local connections into endless opportunity, will take place from June 19 to June 21, 2024, in Shanghai, China.

View More →

Huapont will be actively participating in CPhI China 2024 (Booth No.: W3E52b). This prestigious event, turning local connections into endless opportunity, will take place from June 19 to June 21, 2024, in Shanghai, China.

Huapont Team to Participate API China 2023 (May 15-17, Booth No.: 1.2W03)

2024/04/25

Huapont Team to Participate API China 2023 (May 15-17, Booth No.: 1.2W03)

Huapont will be actively participating in API China 2024 (Booth No.: 1.2W03). This prestigious event, Asia’s leading pharmaceutical show for trading, knowledge sharing and networking, spaning all industry sectors along the pharmaceutical supply chain, will take place from May 15-17, 2024, in Shanghai, China.

View More →

Huapont will be actively participating in API China 2024 (Booth No.: 1.2W03). This prestigious event, Asia’s leading pharmaceutical show for trading, knowledge sharing and networking, spaning all industry sectors along the pharmaceutical supply chain, will take place from May 15-17, 2024, in Shanghai, China.

DCAT Week 2024

2024/03/16

DCAT Week 2024

Time：March 18-21, 2024
Location：New York City
Please send email to api@huapont.cn to make an appointment for meeting. We’ll see you there

View More →

Time：March 18-21, 2024
Location：New York City
Please send email to api@huapont.cn to make an appointment for meeting. We’ll see you there

Huapont Team to Participate DCAT Week 2024 (March 18-21)

2024/02/26

Huapont Team to Participate DCAT Week 2024 (March 18-21)

Huapont will be actively participating in DCAT Week 2024. This prestigious event, known for its high-level business meetings and networking opportunities, will take place from March 18 to March 21, 2024, in New York.

View More →

Huapont will be actively participating in DCAT Week 2024. This prestigious event, known for its high-level business meetings and networking opportunities, will take place from March 18 to March 21, 2024, in New York.

CPHI Barcelona, 2023

2023/09/06

CPHI Barcelona, 2023

Time：October 24-26, 2023
Location：Barcelona
Please send email to api@huapont.cn to make an appointment for meeting. We’ll see you there

View More →

Time：October 24-26, 2023
Location：Barcelona
Please send email to api@huapont.cn to make an appointment for meeting. We’ll see you there

CPHI China, 2023

2023/04/26

CPHI China, 2023

Time：June 19-21, 2023
Location：Shanghai, China
Please send email to api@huapont.cn to make an appointment for meeting. We’ll see you there

View More →

Time：June 19-21, 2023
Location：Shanghai, China
Please send email to api@huapont.cn to make an appointment for meeting. We’ll see you there

CPHI Japan, 2023

2023/04/26

CPHI Japan, 2023

Time：April 19-21, 2023
Location：Japan
Please send email to api@huapont.cn to make an appointment for meeting. We’ll see you there

View More →

Time：April 19-21, 2023
Location：Japan
Please send email to api@huapont.cn to make an appointment for meeting. We’ll see you there

Huapont Would Attend DCAT, March 20-23, 2023

2023/02/21

Huapont Would Attend DCAT, March 20-23, 2023

DCAT Week

View More →

DCAT Week

Huapont is awarded with CEP certificate of Tretinoin

2022/09

Huapont is awarded with CEP certificate of Tretinoin

Huapont Shengchem obtained Ruxolitinib Phosphate WC certificate

2022/05/27

Huapont Shengchem obtained Ruxolitinib Phosphate WC certificate

Huapont Shengchem is one of leading Active Pharmaceutical Ingredients (API) manufacturers and suppliers globally for Ruxolitinib Phosphate (CAS Number: 1092939-17-7) API. DMF (No. 029480）has been submitted to US FDA and it is available for reference. In early time of this month, Huapont shengchem GMP management system has been inspected by Chongqing Municiple Drug Administration. Huapont Shengchem passed the inspection and obtained Ruxolitinib Phosphate WC certificate (Written confirmation for active substances exported to EU). Label of JAKAFI® (Manufactured by Incyte Corporation) showes Ruxolitinib Phosphate tablet is a kinase inhibitor indicated for treatment of: (1) intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis in adults; (2) polycythemia vera in adults who have had an inadequate response to or are intolerant of hydroxyurea; (3)steroid-refractory acute graft-versus-host disease in adult and pediatric patients 12 years and older; (4) chronic graft-versus-host disease after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older. A topical use drug product with new preparation (cream) was newly approved by US FDA in 2021.

View More →

Huapont Shengchem is one of leading Active Pharmaceutical Ingredients (API) manufacturers and suppliers globally for Ruxolitinib Phosphate (CAS Number: 1092939-17-7) API. DMF (No. 029480）has been submitted to US FDA and it is available for reference. In early time of this month, Huapont shengchem GMP management system has been inspected by Chongqing Municiple Drug Administration. Huapont Shengchem passed the inspection and obtained Ruxolitinib Phosphate WC certificate (Written confirmation for active substances exported to EU). Label of JAKAFI® (Manufactured by Incyte Corporation) showes Ruxolitinib Phosphate tablet is a kinase inhibitor indicated for treatment of: (1) intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis in adults; (2) polycythemia vera in adults who have had an inadequate response to or are intolerant of hydroxyurea; (3)steroid-refractory acute graft-versus-host disease in adult and pediatric patients 12 years and older; (4) chronic graft-versus-host disease after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older. A topical use drug product with new preparation (cream) was newly approved by US FDA in 2021.

Huapont was awarded <Certificate of Intellectual Property Management System>

2021/12/22

Huapont was awarded <Certificate of Intellectual Property Management System>

　　On March 1, 2013, was published. It helped raising awareness of intellectual property right, innovation and furtherly enhancing innovation capacity. Recently, intellectual property management system of Huapont was inspected and approved by Zhongbiaotong International Certification (Shenzhen) Co., Ltd. Huapont was awarded .

View More →

　　On March 1, 2013, was published. It helped raising awareness of intellectual property right, innovation and furtherly enhancing innovation capacity. Recently, intellectual property management system of Huapont was inspected and approved by Zhongbiaotong International Certification (Shenzhen) Co., Ltd. Huapont was awarded .

Huapont Life Sciences ranked top 100 private enterprises in Chongqing

2021/10/28

Huapont Life Sciences ranked top 100 private enterprises in Chongqing

On October 9,2021, “2021 Chongqing Top 100 Private Enterprises Summit” was hold in Chongqing, hosted by Chongqing Federation of Industry and Commerce,

View More →

On October 9,2021, “2021 Chongqing Top 100 Private Enterprises Summit” was hold in Chongqing, hosted by Chongqing Federation of Industry and Commerce,

Isotretinoin process 2 obtained CEP certification (No. 2018-219).

2019/01

Isotretinoin process 2 obtained CEP certification (No. 2018-219).

Moxifloxacin Hydrochloride, Olopatadine Hydrochloride and Linezolid obtained the GMP certificate issued by China-NMPA (National Medical Products Administration).

2019/02

Moxifloxacin Hydrochloride, Olopatadine Hydrochloride and Linezolid obtained the GMP certificate issued by China-NMPA (National Medical Products Administration).

Huapont Pharm. has awarded with “2020 Benchmark Intelligent Manufacturer of Chongqing”

2020/09/15

Huapont Pharm. has awarded with “2020 Benchmark Intelligent Manufacturer of Chongqing”

On September 15th, ceremony of “2020 Benchmark Intelligent Manufacturer of Chongqing” was held successfully at The Third Industrial and Intelligent Manufacturing Summit Forum of Smart China Expo Online 2020.

View More →

On September 15th, ceremony of “2020 Benchmark Intelligent Manufacturer of Chongqing” was held successfully at The Third Industrial and Intelligent Manufacturing Summit Forum of Smart China Expo Online 2020.

TDMF for Moxifloxacin HCl is approved by Taiwan FDA

2020/04

TDMF for Moxifloxacin HCl is approved by Taiwan FDA

语言版本

HUAPONT SHENGCHEM

2024/05/09

2024/05/09

2024/05/09

2024/04/27

2024/04/26

2024/04/25

2024/03/16

2024/02/26

2023/09/06

2023/04/26

2023/04/26

2023/02/21

2022/09

2022/05/27

2021/12/22

2021/10/28

2019/01

2019/02

2020/09/15

2020/04

友情链接

地址版权

地址版权手机